ArticleTropical medicine and infectious disease2026
Risk Factors for Poor Neurological Outcomes at Discharge in Tuberculous Meningitis: Disease Severity, Host Factors, and Drug Therapy.
Article in Tropical medicine and infectious disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionThis study investigated independent factors associated with neurological prognosis at discharge in patients with tuberculous meningitis (TBM) and evaluated the impact of intensified treatment regimens.
methodsA retrospective analysis was conducted in 518 TBM patients from two Chinese medical centers. LASSO and multivariable logistic regression were used to identify independent risk factors for poor neurological outcomes. A 1:1 PSM based on intensified treatment exposure was performed to assess its association with neurological outcomes, with an exploratory outcome-based matched comparison conducted for other prognostic factors.
resultsAmong 518 patients, 123 (23.75%) had poor neurological outcomes. The poor-prognosis group had higher proportions of MRC stage III (30.08% vs. 8.35%,
conclusionNeurological prognosis in TBM is influenced by both disease severity and host baseline status. Intensified therapy was not significantly associated with neurological outcome at discharge after adjustment, highlighting the importance of individualized risk management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.